Interestingly, regarding CXCR2 that was expressed at similar levels in T, TA, and TAc, patients with higher CXCR2 expression in tumor samples presented reduced risk of recurrence independent of cancer cell presence in tumor surrounding. This evidence concerns the gene CXCR2 and neoplasm.